CApecitabine Prior to TUmor Resection in Ent Oncology (CAPTURE)

Clinical trial NCT07254962 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07254962
Sponsor: Sir Mortimer B. Davis - Jewish General Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Head Neck Cancer Mouth Cancer Throat Cancer Larynx Cancer Skin Cancer Face

Start date: 2026-01-01
Primary completion: 2028-01-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.